Best Practices and Considerations for Clinical Pharmacology and Pharmacometric Aspects for Optimal Development of CAR‐T and TCR‐T Cell Therapies: An Industry PerspectiveHardik Mody, Vijay Upreti, Vibha Jawa et al.|Clinical Pharmacology & Therapeutics|2023Cited by 26
Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer TherapyPrathap Nagaraja Shastri, Alison Betts, Meric Ovacik et al.|Clinical Pharmacology & Therapeutics|2024Cited by 9